MXPA01002674A - Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional. - Google Patents

Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.

Info

Publication number
MXPA01002674A
MXPA01002674A MXPA01002674A MXPA01002674A MXPA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A MX PA01002674 A MXPA01002674 A MX PA01002674A
Authority
MX
Mexico
Prior art keywords
protein
mhc
cell
process according
functional
Prior art date
Application number
MXPA01002674A
Other languages
English (en)
Spanish (es)
Inventor
Ostergaard Pedersen Lars
Original Assignee
Ostergaard Pedersen Lars
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ostergaard Pedersen Lars filed Critical Ostergaard Pedersen Lars
Publication of MXPA01002674A publication Critical patent/MXPA01002674A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA01002674A 1998-09-14 1999-09-14 Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional. MXPA01002674A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801155 1998-09-14
PCT/DK1999/000484 WO2000015665A2 (fr) 1998-09-14 1999-09-14 Procede de production d'une proteine fonctionnelle de la superfamille des immunoglobulines

Publications (1)

Publication Number Publication Date
MXPA01002674A true MXPA01002674A (es) 2002-06-04

Family

ID=8101632

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01002674A MXPA01002674A (es) 1998-09-14 1999-09-14 Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.

Country Status (10)

Country Link
EP (1) EP1114063A2 (fr)
JP (1) JP2002524104A (fr)
KR (1) KR20010075108A (fr)
CN (1) CN1326466A (fr)
AU (1) AU771239C (fr)
BR (1) BR9914491A (fr)
CA (1) CA2343313A1 (fr)
MX (1) MXPA01002674A (fr)
NZ (1) NZ511031A (fr)
WO (1) WO2000015665A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336167B1 (fr) 2001-03-14 2019-05-29 Dako Denmark A/S Nouvelles constructions de molécules MHC, méthodes d'utilisation de ces constructions à des fins de diagnostic et de therapie et utilisations de molécules MHC
WO2003097669A2 (fr) * 2002-05-17 2003-11-27 Københavns Universitet Procede de purification de proteines denaturees presentant une configuration de liaisons de disulfide voulue
US20040072262A1 (en) * 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2004072112A2 (fr) * 2003-02-11 2004-08-26 Københavns Universitet Procede de preparation de molecules de type mhc pour stockage prolonge
AU2004286307A1 (en) * 2003-10-31 2005-05-12 Vitatex, Inc. Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
WO2006009838A2 (fr) 2004-06-17 2006-01-26 Beckman Coulter, Inc. Epitopes de mycobacterium tuberculosis et leurs procedes d'utilisation
WO2006023782A2 (fr) 2004-08-19 2006-03-02 Biogen Ideca Ma Inc. Repliement des proteines de la famille du facteur de croissance transformant beta
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
CL2007002225A1 (es) * 2006-08-03 2008-04-18 Astrazeneca Ab Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
WO2008116468A2 (fr) 2007-03-26 2008-10-02 Dako Denmark A/S Complexes peptidiques du cmh et leurs utilisations dans des maladies infectieuses
ES2476253T3 (es) 2007-05-01 2014-07-14 Biogen Idec Ma Inc. P�ptidos de neublastina para su uso en el aumento de la vascularizaci�n en tejido con flujo sanguíneo deteriorado
EP2167537A2 (fr) 2007-07-03 2010-03-31 Dako Denmark A/S Procedes compiles pour analyser et trier des echantillons
KR20190140090A (ko) 2007-07-09 2019-12-18 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (fr) 2008-10-02 2010-04-08 Dako Denmark A/S Vaccins moléculaires contre les maladies infectieuses
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
CN103364558A (zh) * 2013-07-17 2013-10-23 江阴泽成生物技术有限公司 一种人肿瘤标志物癌胚抗原（cea）的磁微粒化学发光免疫分析试剂盒及其检测方法
CN109402036A (zh) * 2018-11-07 2019-03-01 河北科技师范学院 牛源肠炎沙门菌trxB基因缺失的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
EP0640094A1 (fr) * 1992-04-24 1995-03-01 The Board Of Regents, The University Of Texas System Production recombinante de domaines semblables a l'immunoglobuline dans des cellules procaryotes
AU4923593A (en) * 1992-09-15 1994-04-12 Rockefeller University, The Major histocompatibility complex molecules and modifications thereof
CA2175089A1 (fr) * 1993-10-25 1995-05-04 Eric T. Rhodes Expression procaryote de proteines du cmh
WO1997044667A2 (fr) * 1996-05-21 1997-11-27 Institut Pasteur Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t

Also Published As

Publication number Publication date
JP2002524104A (ja) 2002-08-06
KR20010075108A (ko) 2001-08-09
EP1114063A2 (fr) 2001-07-11
WO2000015665A3 (fr) 2000-08-17
AU771239B2 (en) 2004-03-18
CN1326466A (zh) 2001-12-12
WO2000015665A2 (fr) 2000-03-23
BR9914491A (pt) 2002-01-15
AU771239C (en) 2004-10-14
NZ511031A (en) 2003-11-28
CA2343313A1 (fr) 2000-03-23
AU5504799A (en) 2000-04-03

Similar Documents

Publication Publication Date Title
MXPA01002674A (es) Un metodo para producir una proteina de la superfamilia de inmunoglobulina funcional.
West et al. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells
Frayser et al. Empty and Peptide-Loaded Class II Major Histocompatibility Complex Proteins Produced by Expression inEscherichia coliand Foldingin Vitro
DE69833949T2 (de) Mutierte klasse-i-mhc-moleküle
EP1844072B1 (fr) Oligomere mhc et procede de fabrication de celui-ci
Parker et al. Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides.
Ignatowicz et al. Cell surface expression of class II MHC proteins bound by a single peptide.
JP2004503213A (ja) １本鎖クラスｉ主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
EP1882700B1 (fr) Complexes majeurs d'histocompatibilite (MHC) biotinylés et leurs utilisations
Hochman et al. Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.
CA3095741A1 (fr) Complexes compacts de peptide-cmh
US20090028884A1 (en) Oligomeric receptor ligand pair member complexes
Purcell et al. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design
JP2004524019A (ja) 内因性蛍光自己多量体化ｍｈｃ融合タンパク質およびその複合体
CN114174329A (zh) 肽-mhc复合物
JP2008528484A (ja) 分子間の非共有的結合性相互作用の破壊のための手段および方法
CA2308463A1 (fr) Cd8 inhibitrices du systeme immunitaire cellulaire
US11814420B2 (en) Peptide deficient-MHC class I/chaperone compositions and methods
Crumpton et al. Molecular structure of the gene products of the human HLA system: isolation and characterization of HLA-A,-B,-C and Ia antigens
Moro et al. Generation of functional HLA-DR* 1101 tetramers receptive for loading with pathogen or tumour derived synthetic peptides
Nag et al. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations
Li et al. Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1
Tussey et al. General introduction to the MHC
US20220387583A1 (en) Recombinant pmhc molecules
US20220275050A1 (en) High yield production and use of enzymatic-exchangeable peptide major histocompatibility complex class i single chain trimer tetramer